Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alimera Sciences Inc (NASDAQ:ALIM)

1.55
Delayed Data
As of May 27
 +0.02 / +1.31%
Today’s Change
1.43
Today|||52-Week Range
5.15
-35.95%
Year-to-Date
No recent news for Alimera Sciences Inc.

Today’s Trading

Previous close1.53
Today’s open1.54
Day’s range1.53 - 1.58
Volume147,942
Average volume (3 months)213,028
Market cap$70.3M
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+24.18%
Earnings growth (this year)+31.12%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+166.39%
P/E ratioNM
Price/Sales4.79
Price/Book--

Competitors

 Today’s
change
Today’s
% change
APDNApplied DNA Sciences...+0.05+1.77%
NVLSNivalis Therapeutics...+0.11+2.36%
ZYNEZynerba Pharmaceutic...+0.16+2.11%
VCELVericel Corp-0.02-0.71%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$22.4M
Annual profit (last year)-$30.6M
Net profit margin-136.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Charles Daniel Myers
President &
Chief Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts

Partner Offers

Search for Jobs